HHS says the elimination of 22 mRNA vaccine development projects for COVID-19 and bird flu signals a shift in vaccine priorities.

The U.S. Department of Health and Human Services said it would wind down mRNA vaccine development activities under its biomedical research unit.

The US Department of Health and Human Services (HHS) plans to cancel $500m (£376m) in funding for mRNA vaccines being developed to counter viruses that cause diseases such as the flu and Covid-19.

The department is canceling 22 projects including awards to Moderna for bird flu vaccine development, contracts with Emory University and rejecting proposals from Pfizer and Sanofi.

The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed to fight respiratory viruses like COVID-19 and the flu.

HHS cancels $776M Moderna contract for avian flu vaccine, signaling a major change in vaccine research approach.

The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed ...

The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has ...

The controversial move affects development of vaccines against COVID-19, flu and H5N1, drawing criticism from public health experts who call it "dangerous." ...

Multiple Massachusetts-based vaccine companies, including Moderna, are affected by U.S. Health and Human Services Secretary Robert F. Kennedy, Jr.'s announcement ending federal support for mRNA ...

The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed to fight respiratory viruses like COVID-19 and the flu.